Case Law Monitor is the bimonthly case law newsletter of the Legislative Analysis and Public Policy Association (LAPPA). Each issue will highlight unique cases from around the United States in the areas of public health and safety, substance use disorders, and the criminal justice system. ...
In this document, the Legislative Analysis and Public Policy Association (LAPPA) determines how health insurance statutes throughout the 50 states, District of Columbia, and all U.S. territories treat mental health and SUD parity....
The purpose of the Model Medicaid Section 1115 Demonstration Waiver Act is to: (1) Require a state department of health and human services to apply for a Medicaid reentry Section 1115 demonstration waiver to allow a state Medicaid program to cover pre-release services for a Medicaid eligible incarcerated individual for up to 90 days prior to the individual’s expected release date and (2) Require a state department of health and human services to conduct comprehensive monitoring and evaluation of the Medicaid reentry demonstration, if the waiver is approved....
The Model Relief from Collateral Consequences of Conviction Act establishes a process for the identification, collection, and publication of state and federal collateral consequences that impact an individual who has been convicted of a crime and establishes a process by which an individual can obtain a certificate of relief from certain collateral consequences before records are eligible to be sealed or expunged....
Each issue of News Bites will highlight unique news articles from around the United States in the areas of public health and safety, substance use disorders, and the criminal justice system. This newsletter will feature stories that you may have missed but are important to the field....
In this fact sheet the Legislative Analysis and Public Policy Association (LAPPA) details the changes to the "primary diagnosis other than OUD" regulation. The fact sheet also covers the federal regulatory scheme for methadone for OUD and explains what led SAMHSA to revise its regulations. ...
The Legislative Analysis and Public Policy Association (LAPPA) is monitoring the emergence of novel psychoactive substances (NPS) appearing on the streets of the United States. This fact sheet, which focuses on Medetomidine, is the seventh in a series that highlights these dangerous drugs. ...
In this document, the Legislative Analysis and Public Policy Association (LAPPA) examines state-level statutes and regulations related to substance use during pregnancy and whether such use during pregnancy is considered child abuse or neglect in the jurisdiction. ...
Case Law Monitor is the bimonthly case law newsletter of the Legislative Analysis and Public Policy Association (LAPPA). Each issue will highlight unique cases from around the United States in the areas of public health and safety, substance use disorders, and the criminal justice system. ...
This document provides a state-by-state review of applicable statewide laws and or regulations related to methamphetamine and methamphetamine precursors....